Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mitiglinide vs Acarbose in Type 2 Diabetes
NCT02143765Phase 4Completed
- Sponsor
- Zhongda Hospital, Southeast University
- Start
- May 2014
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of mitiglinide in type 2 diabetes mellitus (T2DM), sponsored by Zhongda Hospital, Southeast University. Started May 2014; status: completed.
02
Drugs
mitiglinide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02143765.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02143765.